RALEIGH, N.C., Feb. 18, 2020 – Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced an expansion of Dermatology.com, the first and only non-reimbursed, cash-pay program in dermatology in the United States. Four products have been added to the program, which include RENOVA® (tretinoin cream 0.02%), LOPROX® shampoo (ciclopirox 1%), SOLODYN® (minocycline hydrochloride) extended release tablets and the program’s first over-the-counter option, BenzEFoam® (benzoyl peroxide emollient foam 5.3%/9.8%). A new telemedicine platform has also been added, offering patients the ability to consult with a health care professional, order and potentially receive a prescription on-demand for many of the branded dermatology products available in the program.1 Some products, such as SOLODYN® (minocycline hydrochloride) extended release tablets, EFUDEX® (fluorouracil) topical cream, 5%, and ALDARA® (imiquimod) cream, 5%, which are for more serious skin conditions, will require an in-office visit instead.
“We launched Dermatology.com in March 2019 to provide physicians and patients access to proven, branded treatment options for certain disease states that typically encounter coverage hassles and challenges like acne and barrier repair,” said Bill Humphries, president, Ortho Dermatologics. “Now, with the telemedicine platform, the program is making it possible for patients to receive high-quality, well-known, FDA-approved treatments in a convenient, on-demand manner while, at the same time, ensuring patients are directed to see a board-certified dermatologist when their skin conditions require an in-office visit.”